0001127602-24-003588.txt : 20240206 0001127602-24-003588.hdr.sgml : 20240206 20240206170634 ACCESSION NUMBER: 0001127602-24-003588 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240201 FILED AS OF DATE: 20240206 DATE AS OF CHANGE: 20240206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dmytruk Mark E. CENTRAL INDEX KEY: 0001873507 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40097 FILM NUMBER: 24601123 MAIL ADDRESS: STREET 1: C/O SOARING EAGLE ACQUISITION CORP. STREET 2: 955 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10075 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ginkgo Bioworks Holdings, Inc. CENTRAL INDEX KEY: 0001830214 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 872652913 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 27 DRYDOCK AVENUE STREET 2: 8TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: (877) 442-5362 MAIL ADDRESS: STREET 1: 27 DRYDOCK AVENUE STREET 2: 8TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: Soaring Eagle Acquisition Corp. DATE OF NAME CHANGE: 20210210 FORMER COMPANY: FORMER CONFORMED NAME: Spinning Eagle Acquisition Corp. DATE OF NAME CHANGE: 20201027 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-02-01 0001830214 Ginkgo Bioworks Holdings, Inc. DNA 0001873507 Dmytruk Mark E. C/O GINKGO BIOWORKS HOLDINGS, INC. 27 DRYDOCK AVENUE BOSTON MA 02210 1 See remarks 0 Class A Common Stock 2024-02-01 4 M 0 65448 A 781546 D Class A Common Stock 2024-02-01 4 M 0 18125 A 799671 D Class A Common Stock 2024-02-01 4 M 0 1635 A 801306 D Class A Common Stock 2024-02-02 4 S 0 39569 1.208 D 761737 D Restricted Stock Units 2024-02-01 4 M 0 65448 D Class A Common Stock 65448 843335 D Restricted Stock Units 2024-02-01 4 M 0 18125 D Class A Common Stock 18125 670625 D Class B Common Stock 2024-02-01 4 M 0 1635 D Class A Common Stock 1635 631957 D Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. Includes shares of Class B Common Stock that are subject to vesting conditions. Chief Financial Officer /s/ Karen Tepichin, Attorney-in-Fact 2024-02-06